Medical AI has a proof problem

FT argues that medical AI lacks rigorous evidence for clinical deployment. Many models perform well in labs but lack large-scale randomized controlled trials. Regulators and hospitals need stricter validation standards, or adoption will stall. The post doesn't name specific companies or models, but highlights the core tension: tech outpaces proof.